Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700015680

Trial Profile

Clinical Trials Insight: 700015680

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 01 Jun 2009

At a glance

  • Drugs Adecatumumab; Docetaxel
  • Indications Advanced breast cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 01 Jun 2009 Data presented at the annual meeting of the American Society of Clinical Oncology (ASCO 2009), according to a Micromet media release.
    • 15 Sep 2008 Interim results presented at ESMO 2008, according to a Micromet media release.
    • 13 Mar 2008 Data are expected to be presented in the second half of 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top